help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 20, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-1761
A more recent version of this article appeared on February 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/2/543    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Plomgaard, P.
Right arrow Articles by van Hall, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plomgaard, P.
Right arrow Articles by van Hall, G.
Related Collections
Right arrow Autoimmunity
Right arrow Metabolism

Submitted on August 7, 2007
Accepted on November 8, 2007

TNF-alpha modulates human in vivo lipolysis

Peter Plomgaard*, Christian P Fischer, Tobias Ibfelt, Bente K Pedersen, and Gerrit van Hall

The Centre of Inflammation and Metabolism at Department of Infectious Diseases Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark; Copenhagen Muscle Research Centre, Rigshospitalet, Copenhagen, Denmark; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark

* To whom correspondence should be addressed. E-mail: plomgaard{at}dadlnet.dk.

Context: Low-grade systemic inflammation is a feature of most lifestyle-related chronic diseases. Enhanced tumor necrosis factor alpha (TNF-{alpha}) concentrations have been implicated in the development of hyperlipidemia.

Objective: We hypothesized that an acute elevation of TNF-{alpha} in plasma would cause an increase in lipolysis raising circulatory free fatty acid levels.

Subjects and Methods: Using a randomized controlled, crossover design healthy young male individuals (n = 10) received recombinant human (rh) TNF-{alpha} (700 ng·m–2·h–1) for 4h and energy metabolism was evaluated by using a combination of tracer dilution methodology and arterials-venous differences over the leg.

Results: Plasma TNF-{alpha} levels increased from 0.7 ± 0.04 to 16.7 ± 1.8 pg/ml and plasma interleukin-6 (IL-6) increased from 1.0 ± 0.2 to 9.2 ± 1.0 pg/ml (P < 0.05) after 4h of rhTNF-{alpha} infusion. Here we demonstrate that 4h of rhTNF-{alpha} infusion increases whole body lipolysis by 40% (P < 0.05) with a concomitant increase in free fatty acid clearance with no changes in skeletal muscle free fatty acid uptake, release or oxidation. Of note, systemic glucose turnover and lactate and catecholamine levels were unaffected by rhTNF-{alpha} infusion.

Conclusion: This study demonstrates that a relatively low dose of rhTNF-{alpha} induces systemic lipolysis, and that the skeletal muscle fat metabolism is unaffected.


Key words: Cytokines • Fatty Acids • Glucose Turnover • Interleukins • Metabolism







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society